ID20973A - Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi - Google Patents

Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi

Info

Publication number
ID20973A
ID20973A IDP981293A ID981293A ID20973A ID 20973 A ID20973 A ID 20973A ID P981293 A IDP981293 A ID P981293A ID 981293 A ID981293 A ID 981293A ID 20973 A ID20973 A ID 20973A
Authority
ID
Indonesia
Prior art keywords
tolered
polyethylymiminal
bioli
low molecules
compounds low
Prior art date
Application number
IDP981293A
Other languages
English (en)
Inventor
Thomas Prof Dr Kissel
Dagmar Dr Fischer
Hans Peter Dr Elsasser
Thorsten Bieber
Original Assignee
Hoechst Marion Roussel De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel De Gmbh filed Critical Hoechst Marion Roussel De Gmbh
Publication of ID20973A publication Critical patent/ID20973A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Lubricants (AREA)
  • Developing Agents For Electrophotography (AREA)
IDP981293A 1997-09-30 1998-09-28 Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi ID20973A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19743135A DE19743135A1 (de) 1997-09-30 1997-09-30 Biologisch verträgliche niedermolekular Polyethylenimine

Publications (1)

Publication Number Publication Date
ID20973A true ID20973A (id) 1999-04-01

Family

ID=7844109

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP981293A ID20973A (id) 1997-09-30 1998-09-28 Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi

Country Status (19)

Country Link
US (2) US8003734B2 (id)
EP (1) EP0905254B1 (id)
JP (1) JP4399042B2 (id)
KR (1) KR19990030290A (id)
AR (1) AR015726A1 (id)
AT (1) ATE324397T1 (id)
AU (1) AU758239B2 (id)
BR (1) BR9803982A (id)
CA (1) CA2249058A1 (id)
CY (1) CY1105109T1 (id)
CZ (1) CZ310598A3 (id)
DE (2) DE19743135A1 (id)
DK (1) DK0905254T3 (id)
ES (1) ES2264180T3 (id)
HU (1) HUP9802157A3 (id)
ID (1) ID20973A (id)
PL (1) PL328910A1 (id)
PT (1) PT905254E (id)
TR (1) TR199801933A2 (id)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19956029A1 (de) * 1999-11-22 2001-05-23 Aventis Pharma Gmbh Trägersysteme enthaltend Hüllsubstanzen mit enzymatisch abspaltbaren Seitengruppen
DE19960206A1 (de) * 1999-12-14 2001-07-19 Frank Czubayko Komplexierung von RNS mit Polyethyleniminen zur deren Stabilisierung und zellulären Einschleusung
FR2805271B1 (fr) * 2000-02-18 2002-04-26 Aventis Pharma Sa Procede de preparation de polyalkylenimines fonctionnalises, compositions les contenant et leurs utilisations
IL151289A0 (en) * 2000-02-18 2003-04-10 Aventis Pharma Sa Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof
US6696038B1 (en) * 2000-09-14 2004-02-24 Expression Genetics, Inc. Cationic lipopolymer as biocompatible gene delivery agent
DE10145134A1 (de) * 2000-10-09 2002-05-16 Bayer Ag Komplexe zur Einführung von Nukleinsäuren in Zellen
CA2424967A1 (en) * 2000-10-09 2003-04-04 Bayer Aktiengesellschaft Complexes for transferring nucleic acids into cells
WO2003038103A1 (en) * 2001-10-29 2003-05-08 Atso Raasmaja Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers
US7824910B2 (en) 2001-11-29 2010-11-02 Nippon Shokubai Co., Ltd. Method of transducing a protein into cells
WO2003072637A1 (en) * 2002-02-22 2003-09-04 Insert Therapeutics, Inc. Carbohydrate-modified polymers, compositions and uses related thereto
US20040048260A1 (en) * 2002-09-10 2004-03-11 Fu-Hsiung Chang Transfection of nucleic acid
US20040138154A1 (en) 2003-01-13 2004-07-15 Lei Yu Solid surface for biomolecule delivery and high-throughput assay
US7153905B2 (en) * 2003-03-21 2006-12-26 The General Hospital Corporation Hyperbranched dendron and methods of synthesis and use thereof
JP2007043972A (ja) * 2005-08-10 2007-02-22 Tokyo Institute Of Technology アパタイト粒子及びその作製方法、遺伝子−アパタイト粒子複合体及びその作製方法、並びに遺伝子導入方法及び遺伝子導入用キット
US20080145893A1 (en) * 2006-09-17 2008-06-19 Excellegene Sa Method for producing a recombinant protein at high specific productivity, high batch yield and high volumetric yield by means of transient transfection
EP2183297A2 (en) * 2007-07-31 2010-05-12 PolyPlus Transfection Method for manufacturing linear polyethylenimine (pei) for transfection purpose and linear pei obtained with such method
FR2928373B1 (fr) * 2008-03-05 2010-12-31 Centre Nat Rech Scient Polymere derive de la polyethylenimine lineaire pour le transfert de gene.
EP2623117A1 (en) 2009-04-30 2013-08-07 Genetic Immunity Kft. Immunogenic nanomedicine composition and preparation and uses thereof
US20130079382A1 (en) 2009-10-12 2013-03-28 Larry J. Smith Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro
US10722462B2 (en) * 2014-12-10 2020-07-28 Council Of Scientific And Industrial Research Discontinuous reverse micellar composition in cubic FD3M phase for sustained release of therapeutic drugs
JP6873418B2 (ja) * 2016-11-11 2021-05-19 国立大学法人北陸先端科学技術大学院大学 遺伝子導入された細胞の製造方法及びポリエチレンイミンの置換体ポリマー
EP3548890B1 (en) 2016-12-01 2024-03-27 Norbert Gretz Means and methods for visualization of tissue structures
CN112237633B (zh) * 2020-10-22 2023-06-27 林君玉 一种pei/on复合物及其制备方法和用途

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2182306A (en) * 1935-05-10 1939-12-05 Ig Farbenindustrie Ag Polymerization of ethylene imines
NL45673C (id) * 1935-05-11
DE2530042C3 (de) * 1975-07-04 1982-04-22 Institut neftechimičeskogo sinteza imeni A.V. Topčieva Akademii Nauk SSSR, Moskva Verfahren zur Herstellung von linearem Polyäthylenimin
US4032480A (en) * 1975-07-11 1977-06-28 David Solomonovich Zhuk Method of producing linear polyethylenimine
GB2128625B (en) * 1982-10-07 1986-01-08 Inst Neftechimicheskogo Sintez Method for preparing branched polyethylenimine
US4599400A (en) 1984-12-18 1986-07-08 The Dow Chemical Company Star/comb-branched polyamide
GB8621337D0 (en) * 1986-09-04 1986-10-15 Agricultural Genetics Co Non-radioactive nucleic acid hybridization probes
US5977307A (en) 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
US6036955A (en) 1992-03-05 2000-03-14 The Scripps Research Institute Kits and methods for the specific coagulation of vasculature
IL128774A (en) 1994-03-07 2001-05-20 Dow Chemical Co Composition comprising a dendritic poymer in complex with at least one unit of biological response modifier and a process for the preparation thereof
FR2722506B1 (fr) * 1994-07-13 1996-08-14 Rhone Poulenc Rorer Sa Composition contenant des acides nucleiques, preparation et utilisations
CA2226299A1 (en) 1995-08-11 1997-02-27 Dendritech, Inc. Hyper comb-branched polymer conjugates
CN1196711A (zh) * 1995-09-18 1998-10-21 德尔塔化学有限公司 聚氯化铝和聚氯硫酸铝的制备方法及组合物
DE19605279A1 (de) 1996-02-13 1997-08-14 Hoechst Ag Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung
US5962429A (en) * 1996-11-22 1999-10-05 University Of Iowa Complexes of adenovirus with cationic molecules
DE19649645A1 (de) 1996-11-29 1998-06-04 Hoechst Ag Mehrfach funktionelles Ligandensystem zur zielzellspezifischen Übertragung von Nukleotidsequenzen
US5830730A (en) 1997-05-08 1998-11-03 The Regents Of The University Of California Enhanced adenovirus-assisted transfection composition and method

Also Published As

Publication number Publication date
CZ310598A3 (cs) 1999-04-14
US20110306656A1 (en) 2011-12-15
HUP9802157A2 (hu) 1999-06-28
EP0905254B1 (de) 2006-04-26
TR199801933A2 (xx) 1999-04-21
HUP9802157A3 (en) 2003-02-28
AU758239B2 (en) 2003-03-20
PL328910A1 (en) 1999-04-12
EP0905254A3 (de) 2002-01-02
EP0905254A2 (de) 1999-03-31
DE19743135A1 (de) 1999-04-01
DK0905254T3 (da) 2006-08-21
JPH11187874A (ja) 1999-07-13
CY1105109T1 (el) 2009-11-04
AR015726A1 (es) 2001-05-16
AU8714898A (en) 1999-04-22
US20030027784A1 (en) 2003-02-06
KR19990030290A (ko) 1999-04-26
PT905254E (pt) 2006-08-31
ES2264180T3 (es) 2006-12-16
HU9802157D0 (en) 1998-12-28
JP4399042B2 (ja) 2010-01-13
US8003734B2 (en) 2011-08-23
CA2249058A1 (en) 1999-03-30
BR9803982A (pt) 2000-03-28
DE59813507D1 (de) 2006-06-01
ATE324397T1 (de) 2006-05-15

Similar Documents

Publication Publication Date Title
ID20973A (id) Senyawa-senyawa polietilenimina berat molekul rendah yang dapat ditoleransi secara biologi
ID19875A (id) Poliolefin yang dimodifikasi menurut reologi
ID28110A (id) Surfaktan alkilbenzenasulfonat yang disempurnakan
ID17315A (id) Perekat yang dapat digabungkan secara hayati
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
ID24053A (id) Rakitan penghubung yang dapat dilepas untuk senapan pelubang
ID26509A (id) Komponen-komponen yang mengandung tetrahidrolipstatin
ID16493A (id) Perlakuan bahan yang mengandung padatan yang diambil dari efluen
BR9710416A (pt) Compostos de ïÕïster de betaina de alcoÄis ativos
ID24372A (id) SENYAWA-SENYAWA 4-AMINO-TIAZOL-2-IL SEBAGAI PENGHAMBAT-PENGHAMBAT CDKs
DE69608448D1 (de) Reduktion des biobewuchses
ID21556A (id) Pirazol yang bersifat parasitisida
ID24314A (id) Tempat umpan bersekat-sekat
CY2006003I2 (el) Χρηση δαπτομυκινης
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
ID28615A (id) Komposisi yang terdiri dari sefuroksim aksetil
ID29966A (id) Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID24270A (id) Penghilang sumbatan keratotik
ID24677A (id) Kombinasi senyawa aktif fungisidal
ID16838A (id) Komposisi dekafluoropentana
ID23429A (id) Komposisi-komposisi sertralina yang larut
ID23437A (id) Penghilang sumbatan keratotik
EE9700220A (et) Ainesegu
ID24132A (id) Komposisi pembersih yang bersifat abrasif
ID22787A (id) Nitro-benzamida berguna sebagai zat anti - arritimia